| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Dec―25 |
Factors associated with the development of atrial fibrillation in COVID-19 patients |
T. V. Kanaeva, L. A. Nemtseva, N. A. Karoli |
| 2 |
[GO] |
2024―Dec―23 |
Morphological characteristics of the lungs in COVID-19 patients with diseases of the blood system |
V. A. Nevzorova, A. V. Tal'ko, E. A. Kotsyurbiy, V. Yu. Parinov, Z. E. Putiy |
| 3 |
[GO] |
2024―Dec―23 |
Features of the course of non-alcoholic fatty liver disease after COVID-19 |
K. S. Zhuk, E. I. Tarlovskaya, T. V. Vlasova |
| 4 |
[GO] |
2024―Jun―26 |
The structure of traumatic brain injury in the city of Rostov-on-Don during the new coronavirus infection COVID 19 |
V. V. Efremov, I. V. Balyazin-Parfenov, A. V. Papazova, A. Y. Magomedova, E. M. Hantimeryan |
| 5 |
[GO] |
2023―Dec―27 |
Features of the arterial hypertension course and arterial stiffness in patients with ankylosing spondylitis who get infected COVID-19 |
L. R. Bogdalova, N. M. Nikitina, M. I. Yupatova, A. P. Rebrov |
| 6 |
[GO] |
2023―Dec―27 |
Dynamics of lipid metabolism in hypertensive patients who have had COVID-19 when the L-arginine + dihydroquercetin complex is included in the combined antihypertensive pharmacotherapy |
S. V. Nalotov, O. S. Nalotova, E. B. Serdiuk, E. N. Nalotova, M. M. Alesinsky, I. A. Sidorenko |
| 7 |
[GO] |
2023―Dec―27 |
Features of the course of bronchial asthma in patients who have suffered a new coronavirus infection |
N. V. Kiseleva, E. I. Tarlovskaya, M. V. Boldina |
| 8 |
[GO] |
2023―Jul―07 |
Clinical features of ischemic heart disease in patients after COVID-19 infection and coronary artery bypass graft surgery |
A. O. Loginova, E. I. Tarlovskaya, L. N. Ancigina, P. V. Pimenova |
| 9 |
[GO] |
2023―Apr―06 |
The Frequency and the character of bacterial infection in patients with COVID-19 |
N. A. Karoli, A. P. Rebrov |
| 10 |
[GO] |
2023―Jan―01 |
Combination of granulomatosis with polyangiitis with COVID-19: difficulties in differential diagnosis and treatment |
N. M. Nikitina, O. L. Aleksandrova, N. A. Magdeeva, I. F. Melekhina, N. V. Pasechnaya |
| 11 |
[GO] |
2022―Oct―05 |
Markable coagulopathy in the patient with severe COVID-19 |
A. A. Roshchina, M. I. Yupatova, N. M. Nikitina |
| 12 |
[GO] |
2022―Oct―05 |
COVID-19 and arrhythmias - is there a relationship? |
V. A. Akhmedov, M. A. Livzan, O. V. Gaus |
| 13 |
[GO] |
2022―Jul―05 |
Antibacterial therapy for patients with COVID-19 in outpatients care |
N. A. Karoli, T. V. Kanaeva, M. V. Grashkina, A. P. Rebrov |
| 14 |
[GO] |
2022―Mar―29 |
Teaching therapy in a pandemic: lessons and perspectives |
E. Yu. Ponomareva, K. D. Dorogoikina, A. P. Rebrov |
| 15 |
[GO] |
2021―Jul―07 |
Violation of hemostasis in coronavirus infection |
Yu. V. Shatohin, I. V. Snezhko, E. V. Ryabikina |
| 16 |
[GO] |
2021―Mar―25 |
COVID-19 and obesity: what is known about the features of pathogenesis and treatment? |
S. G. Kanorskii |
| 17 |
[GO] |
2021―Mar―25 |
Association of general blood count indicators with the severity of COVID-19 in hospitalized patients |
N. S. Gubenko, A. A. Budko, A. G. Plisyuk, I. A. Orlova |
| 18 |
[GO] |
2021―Mar―25 |
Evaluation of the factors affecting the formation of humoral immunity to the SARS-COV-2 coronavirus in medical students and doctors of the Republic of Crimea during active phase of the COVID-19 pandemia |
A. V. Kubyshkin, I. I. Fomochkina, E. S. Krutikov, T. P. Sataieva, E. S. Ageeva, А. N. Zakharova |
| 19 |
[GO] |
2020―Oct―13 |
The impact of statins on the course of a new coronavirus infection: myth or reality? |
E. I. Tarlovsky |
